PharmaBlock Sciences (Nanjing), Inc. (SHE:300725)
31.85
+0.35 (1.11%)
Apr 25, 2025, 3:04 PM CST
SHE:300725 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 645.48 | 290.2 | 511.19 | 1,150 | 699.63 | 1,245 | Upgrade
|
Short-Term Investments | - | - | 984.26 | 303.46 | 100.74 | 25 | Upgrade
|
Trading Asset Securities | 295.47 | 465.61 | 105.35 | 163.3 | 304.43 | 107.62 | Upgrade
|
Cash & Short-Term Investments | 940.96 | 755.81 | 1,601 | 1,617 | 1,105 | 1,377 | Upgrade
|
Cash Growth | 42.44% | -52.79% | -1.01% | 46.38% | -19.79% | 511.93% | Upgrade
|
Accounts Receivable | 364.67 | 483.69 | 473.66 | 330.61 | 201.27 | 167.08 | Upgrade
|
Other Receivables | 1.94 | 1.92 | 2.62 | 1.83 | 2.11 | 1.31 | Upgrade
|
Receivables | 366.61 | 485.61 | 476.28 | 332.44 | 203.38 | 168.39 | Upgrade
|
Inventory | 780.9 | 840.17 | 724.79 | 676.39 | 447.94 | 309.63 | Upgrade
|
Other Current Assets | 625.5 | 635.36 | 15.88 | 33.8 | 47.89 | 17.77 | Upgrade
|
Total Current Assets | 2,714 | 2,717 | 2,818 | 2,660 | 1,804 | 1,873 | Upgrade
|
Property, Plant & Equipment | 1,664 | 1,684 | 1,753 | 1,661 | 1,173 | 309.36 | Upgrade
|
Long-Term Investments | 19.54 | 19.86 | 5.48 | 5.66 | 8.91 | 156.97 | Upgrade
|
Goodwill | 355.74 | 355.74 | 356.19 | 356.19 | 356.19 | 31.2 | Upgrade
|
Other Intangible Assets | 106.54 | 107.98 | 109.42 | 111.48 | 111.47 | 33.83 | Upgrade
|
Long-Term Deferred Tax Assets | 35.34 | 32.63 | 38.61 | 35.8 | 15.1 | 11.66 | Upgrade
|
Long-Term Deferred Charges | 6.25 | 6.94 | 10.14 | 9.18 | 7.24 | 2.35 | Upgrade
|
Other Long-Term Assets | 13.44 | 10.99 | 13.1 | 22.8 | 30.74 | 6.71 | Upgrade
|
Total Assets | 4,915 | 4,935 | 5,104 | 4,862 | 3,507 | 2,425 | Upgrade
|
Accounts Payable | 259.14 | 292.2 | 278.7 | 413.47 | 267.35 | 183.68 | Upgrade
|
Accrued Expenses | 46.98 | 82.48 | 104.71 | 88.18 | 60.61 | 30.72 | Upgrade
|
Short-Term Debt | 230.19 | 230.27 | 236.5 | 163.4 | 347.64 | 120.44 | Upgrade
|
Current Portion of Long-Term Debt | 12.07 | 54 | 371.43 | 17.29 | 7.95 | - | Upgrade
|
Current Portion of Leases | - | - | 1.99 | - | 1.82 | - | Upgrade
|
Current Income Taxes Payable | 31.25 | 27.2 | 15.7 | 0.85 | 0.15 | 10.84 | Upgrade
|
Current Unearned Revenue | 97.82 | 56.12 | 32.73 | 39.63 | 28.7 | 57.32 | Upgrade
|
Other Current Liabilities | 5.73 | 6.96 | 14.33 | 16.35 | 74.66 | 72.94 | Upgrade
|
Total Current Liabilities | 683.19 | 749.23 | 1,056 | 739.18 | 788.88 | 475.94 | Upgrade
|
Long-Term Debt | 1,136 | 1,127 | 1,138 | 1,392 | 23.6 | - | Upgrade
|
Long-Term Leases | 4.37 | 3.21 | 0.23 | - | - | - | Upgrade
|
Long-Term Unearned Revenue | 44.52 | 45.71 | 52.64 | 52.85 | 54.14 | 53.63 | Upgrade
|
Long-Term Deferred Tax Liabilities | 21.54 | 22.13 | 24.31 | 20.15 | 12.58 | 1 | Upgrade
|
Other Long-Term Liabilities | 0.9 | 0.9 | - | - | - | - | Upgrade
|
Total Liabilities | 1,891 | 1,948 | 2,272 | 2,205 | 879.21 | 530.57 | Upgrade
|
Common Stock | 199.73 | 199.73 | 199.66 | 199.66 | 199.7 | 153.62 | Upgrade
|
Additional Paid-In Capital | 1,097 | 1,096 | 1,090 | 1,075 | 1,299 | 1,313 | Upgrade
|
Retained Earnings | 1,632 | 1,597 | 1,439 | 1,261 | 967.1 | 495.91 | Upgrade
|
Treasury Stock | -30.04 | -30.04 | -20.03 | - | -35 | -64.58 | Upgrade
|
Comprehensive Income & Other | 125.4 | 125.24 | 123.52 | 121.74 | -3.44 | -3.13 | Upgrade
|
Total Common Equity | 3,024 | 2,988 | 2,832 | 2,658 | 2,427 | 1,895 | Upgrade
|
Minority Interest | - | - | - | 0 | 200.29 | 0 | Upgrade
|
Shareholders' Equity | 3,024 | 2,988 | 2,832 | 2,658 | 2,628 | 1,895 | Upgrade
|
Total Liabilities & Equity | 4,915 | 4,935 | 5,104 | 4,862 | 3,507 | 2,425 | Upgrade
|
Total Debt | 1,383 | 1,414 | 1,749 | 1,573 | 381.02 | 120.44 | Upgrade
|
Net Cash (Debt) | -441.9 | -658.2 | -147.83 | 44.11 | 723.78 | 1,257 | Upgrade
|
Net Cash Growth | - | - | - | -93.91% | -42.42% | 663.04% | Upgrade
|
Net Cash Per Share | -2.21 | -3.30 | -0.73 | 0.22 | 3.63 | 6.69 | Upgrade
|
Filing Date Shares Outstanding | 198.84 | 201.63 | 198.83 | 199.66 | 199.7 | 199.7 | Upgrade
|
Total Common Shares Outstanding | 198.84 | 201.63 | 198.83 | 199.66 | 199.7 | 199.7 | Upgrade
|
Working Capital | 2,031 | 1,968 | 1,762 | 1,921 | 1,015 | 1,397 | Upgrade
|
Book Value Per Share | 15.21 | 14.82 | 14.24 | 13.31 | 12.16 | 9.49 | Upgrade
|
Tangible Book Value | 2,562 | 2,524 | 2,367 | 2,190 | 1,960 | 1,830 | Upgrade
|
Tangible Book Value Per Share | 12.88 | 12.52 | 11.90 | 10.97 | 9.81 | 9.16 | Upgrade
|
Buildings | - | - | 905.31 | 844.6 | 344.88 | 81.95 | Upgrade
|
Machinery | - | - | 1,025 | 792.72 | 510.13 | 151.75 | Upgrade
|
Construction In Progress | - | - | 256.23 | 357.53 | 575.32 | 171.25 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.